Treatment groups |
Viral load
Copies per ml |
Newborn prophylactic group |
N* (%) |
Mono-Dual therapy
(136) |
VL<400
(48/88)* |
AZT alone |
36/48 (75%) |
AZT+3TC or AZT+NVP |
12/48 (25%) |
VL>1.000
(35/88) |
AZT alone |
7/35 (20%) |
AZT+3TC or AZT+NVP |
28/35 (80%) |
HAART
(166) |
VL<400
(136/166) |
AZT alone |
105/136 (77%) |
AZT+3TC or AZT+NVP |
31/136 (23%) |
VL>1.000
(20/166) |
AZT alone |
12/20 (60%) |
AZT+3TC or AZT+NVP |
8/20 (40%) |
*: number of positive values/ total number of values, VL: viral load |